C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 307/94 (2006.01) A61K 31/495 (2006.01) C07D 209/96 (2006.01) C07D 295/06 (2006.01) C07D 295/073 (2006.01) C07D 295/08 (2006.01) C07D 295/112 (2006.01) C07D 295/14 (2006.01) C07D 295/155 (2006.01) C07D 333/50 (2006.01) C07D 333/58 (2006.01)
Patent
CA 2264549
This invention relates to novel, pharmaceutically active compounds of formula (I) wherein a, b and R1 through R6 are defined as in the specification. These compounds exhibit central dopaminergic activity and are useful in the treatment of CNS disorders.
L'invention concerne de nouveaux composés pharmaceutiquement actifs, de formule (I), dans laquelle a, b et R<1> à R<6> sont tels que définis dans la spécification. Ces composés ont une activité dopaminergique centrale et sont utiles dans le traitement des troubles du système nerveux central.
Butler Todd William
Fliri Anton Franz Joseph
Pfizer Inc.
Smart & Biggar
LandOfFree
Spirocyclic dopamine receptor subtype ligands does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Spirocyclic dopamine receptor subtype ligands, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Spirocyclic dopamine receptor subtype ligands will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1636783